Therapeutic Efficacy of Tomex (Allicin) versus Metronidazole in Experimental Giardia lamblia infection: Ultrastructural and Histopathological studies
Yousef, A., sanad, M., Abo El Maaty, D., Farag, T. (2022). Therapeutic Efficacy of Tomex (Allicin) versus Metronidazole in Experimental Giardia lamblia infection: Ultrastructural and Histopathological studies. EKB Journal Management System, 28(1), 8-17. doi: 10.21608/zumj.2019.16238.1456
Asmaa Yousef; magda mostafa sanad; Dalia Abd El Khalik Abo El Maaty; Tahani Ismail Farag. "Therapeutic Efficacy of Tomex (Allicin) versus Metronidazole in Experimental Giardia lamblia infection: Ultrastructural and Histopathological studies". EKB Journal Management System, 28, 1, 2022, 8-17. doi: 10.21608/zumj.2019.16238.1456
Yousef, A., sanad, M., Abo El Maaty, D., Farag, T. (2022). 'Therapeutic Efficacy of Tomex (Allicin) versus Metronidazole in Experimental Giardia lamblia infection: Ultrastructural and Histopathological studies', EKB Journal Management System, 28(1), pp. 8-17. doi: 10.21608/zumj.2019.16238.1456
Yousef, A., sanad, M., Abo El Maaty, D., Farag, T. Therapeutic Efficacy of Tomex (Allicin) versus Metronidazole in Experimental Giardia lamblia infection: Ultrastructural and Histopathological studies. EKB Journal Management System, 2022; 28(1): 8-17. doi: 10.21608/zumj.2019.16238.1456

Therapeutic Efficacy of Tomex (Allicin) versus Metronidazole in Experimental Giardia lamblia infection: Ultrastructural and Histopathological studies

Zagazig University Medical Journal
Article 2, Volume 28, Issue 1, January 2022, Page 8-17  XML PDF (949.02 K)
Document Type: Original Article
DOI: 10.21608/zumj.2019.16238.1456
View on SCiNiTO View on SCiNiTO
Authors
Asmaa Yousef email 1; magda mostafa sanad2; Dalia Abd El Khalik Abo El Maaty3; Tahani Ismail Faragorcid 4
1Assistant lecturer parasitology department faculty of medicine zagazig university
2professor of parasitology department, zagazig university , al sharquia
3professor of parasitology department faculty of medicine zagazig university, zagazig al sharquia
4Assistant professor, faculty of medicine, zagazig university, zagazig, al sharquia
Abstract
Background: Giardia lamblia, a protozoan intestinal flagellate, is the causative agent of human giardiasis allover the world. The current therapeutic agents have considerable adverse effects or be contraindicated in certain clinical situations and may show failure due to drug resistance. Aim of the study: This study was to evaluate the in vivo therapeutic efficacy of Tomex versus Meteronidazole against giardiasis; to declare the histopathological changes of the intestinal mucosa, and their impact on the ultrastructure of the pathogenic trophozoites. Material and Methods: Fourty seven Swiss albino mice divided as following: Group I: 2 non-infected, non-treated mice. Group II: 15 mice, only infected (non-treated). Group III: 15 mice, infected with G. lamblia cysts and treated orally with Tomex. Group IV: 15 mice, infected with G. lamblia cysts and treated orally with Metronidazole. These mice were subjected to parasitological, histopathological and ultrastructural studies. Results: The patent period, intensity of infection, cyst shedding and cure rate in groups treated by Tomex revealed a highly significant difference in comparison with the non-treated control and insignificant difference in comparison with Metronidazole, a finding that might be beneficial in clinical situations, at least, where current chemotherapy is contraindicated. Conclusion: Tomex proved to be injurious to the parasite with evident morphological changes; causing improvement of histopathological changes of the intestinal mucosa, rapid clearance of the parasite and control of giardiasis.
Keywords
Giardia; Mice; Tomex; histopathology; Ultrastructure
Supplementary Files
Statistics
Article View: 565
PDF Download: 856